TubeRank
PATHBullpending
Meet KevinMeet Kevin

Target Price

$52

So I get to a price target of $52 for the stock at fair value.

Thesis at the time

Strongly Bullish

Kevin argues UiPath is transitioning from pure robotic process automation to an AI-augmented RPA platform, mirroring Palantir's playbook at a fraction of the valuation. He believes the company's improving cash flow, strong balance sheet, and low Wall Street expectations set up a significant re-rating opportunity, especially given elevated short interest.

Key arguments

  • UiPath is combining RPA with AI similar to Palantir's 'sovereign AI' approach
  • Net revenue retention improved to 109% for the first time in 3.5 years
  • High-spend customer cohorts ($100k+ and $1M+ spend) are growing 11-18%
  • Company generates a ~6.5% cash flow yield and holds over $1 billion in net cash
  • Wall Street price targets (NEEDM $15, UBS $20) are low, leaving room for upside surprise
  • Short interest is over 30%, raising short squeeze potential

Counter-arguments acknowledged

  • Small and medium business customer attrition is occurring as SMBs cut software spend
  • Wells Fargo expects net revenue retention to decline again
  • Reliance on token-based AI costs could pressure margins
  • Enterprise software market consolidation could erode pricing power
  • Still considered a 'prove me' story before AI-driven growth accelerates

Hedges and caveats (from the video)

  • Video title uses superlative language ('EASY 3x') which may overstate conviction
  • Short squeeze potential is speculative and dependent on market dynamics
  • Company is 52x smaller than comparable Palantir, indicating different risk/growth profile
  • AI hallucination risks acknowledged for certain use cases, but UiPath's niche positioning presented as protective factor
  • No explicit disclaimer of financial advice provided in transcript excerpt

The call

Date said
Aug 15, 2026
Current price (live)
$13.25$38.75 below target
Confidence
medium
Specificity
specific

How it resolved

Status
pending

Confidence Reasoning

Kevin presents this as his own calculated fair value using Wall Street EPS estimates and his own growth assumption, giving it specificity, but he doesn't attach a firm timeframe, which limits certainty.